1 |
Kandhare AD, Alam J, Patil MV, et al. Wound healing potential of naringin ointment formulation via regulating the expression of inflammatory, apoptotic and growth mediators in experimental rats[J]. Pharm Biol, 2016, 54(3):419-432.
|
2 |
Lobmann R, Ambrosch A, Schultz G. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients[J]. Diabetologia, 2002, 45(7):1011-1016.
|
3 |
Heljasvaara R, Nyberg P, Luostarinen J, et al. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases[J]. Exp Cell Res, 2005, 307(2):292-304.
|
4 |
Kato T, Kure T, Chang JH, et al. Diminished corneal angiogenesis in gelatinase A-deficient mice[J]. Febs Letters, 2001, 508(2):187-190.
|
5 |
洪珊珊. ADA:糖尿病医学诊治标准—2011(概要)[J]. 中国糖尿病杂志,2011, 19(2):85-93.
|
6 |
国际血管联盟中国分会糖尿病足专业委员会. 糖尿病足诊治指南[J]. 介入放射学杂志,2013, 22(9):705-708.
|
7 |
Ladwig GP, Robson MC, Liu R, et al. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers[J]. Wound Repair Regen, 2002, 10(1):26-37.
|
8 |
Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech[J]. Microsc Res Tech, 2003, 60(1):107-114.
|
9 |
Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments[J]. Wound Repair Regen, 1996, 4(3):321-325.
|
10 |
Liu Y, Min D, Bolton T, et al. Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers[J]. Diabetes Care, 2009, 32(1):117-119.
|
11 |
陈伟,付小兵,孙同柱,等. 内皮细胞生长因子表达质粒的构建及其促进烫伤愈合的研究[J]. 中华实验外科杂志,2002, 19(2):144-146.
|
12 |
Galeano M, Deodato, Altavilla D, et al. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury[J]. Crit Care Med, 2003, 31(4):1017-1025.
|
13 |
Koyama J, Miyake S, Sasayama T, et al. The novel VEGF receptor antagonist,VGA1155,reduces edema,decreases infarct and improves neurological function after stroke in rats[J]. Kobe J Med Sci, 2010, 56(1):E1-E11.
|
14 |
Watanabe M, Boyer JL, Crystal RG. Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema[J]. Hum Gene Ther, 2009, 20(6):598-610.
|
15 |
Boras I, Lazic R, Gabric N, et al. Anti-VEGF in treatment of diabetic macular edema[J]. Coll Antropol, 2011, 35(2):15-18.
|
16 |
Wall SJ, Bevan D, Thomas DW, et al. Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse[J]. J Invest Derm atol, 2002, 119(1):91-98.
|
17 |
Kähäri VM, Saarialho-Kere U,et al. Matrix metalloproteinases in skin[J]. Exp Dermatol, 1997, 6(5):199-213.
|
18 |
Soo C, Shaw WW, Zhang X,et al.Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair[J]. Plast Reconstr Surg, 2000, 105(2):638-647.
|
19 |
Yager DR, Zhang LY, Liang HX, et al. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids[J]. J Invest Dermatol, 1996, 107(5):743-748.
|
20 |
Poulaki V, Qin W, Joussen AM, et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1 alpha and VEGF[J]. J Clin Invest, 2002, 109(6):805-815.
|